MedPath

Marwo-D Research -Need for Vitamin D in Different Population Groups

Not Applicable
Completed
Conditions
Serum 25-hydroxyvitamin D Concentrations (25OHD)
Interventions
Dietary Supplement: Vitamin D3
Registration Number
NCT02212223
Lead Sponsor
University of Helsinki
Brief Summary

Insufficient intake of vitamin D is a public health problem, affecting about 40% of the Finnish population in the winter. Vitamin D has a wide range of health effects: in addition to its effect on bone, it is known to affect inflammatory response among other things. The sources of vitamin D are the synthesis in the skin as well as diet and dietary supplements. In Finland and in Northern Europe vitamin D is formed in the skin only from March to October. This alone is not sufficient to cover the need for year-round, because vitamin D storage is used in a few months. During the winter months the only sources of vitamin D are diet and vitamin preparations. Current vitamin D recommendations are usually based on studies in white population. However, there can be a difference in the need of vitamin D and in vitamin D metabolism between different population groups. More research evidence is needed from the northern countries. The aim of this study is to evaluate the vitamin D need in Somali immigrant population and in original Finnish population. The hypothesis is that the Somalis need more vitamin D to exceed the serum 25(OH)D concentration of 50 nmol/L than the original Finnish population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
147
Inclusion Criteria
  • woman between 21-66 years of age
  • belongs to original Finnish population or to Somali immigrant population
  • healthy (= no disease requiring medication)
  • lives in the metropolitan area
Exclusion Criteria
  • pregnant or breastfeeding
  • has traveled to a sunny destination or destination near the equator during the previous month
  • plans to travel to a sunny destination or destination near the equator in the next 6 months
  • has used a tanning bed during the previous month
  • plans to use a tanning bed in the next 6 months
  • the subject's blood 25-hydroxy-vitamin D level (25 (OH) D), exceeds 100 nmol / L or is less than 30 nmol / L at baseline in the screening phase.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 1: Somali immigrant group, 10 µg (400 IU) vitamin D3Vitamin D3Subjects belonging to Somali immigrant population are given a daily supplement containing 10 µg (400 IU) vitamin D3 to take for 6 months
Group 2: Somali immigrant group, 20 µg (800 IU) vitamin D3Vitamin D3Subjects belonging to Somali immigrant population are given a daily supplement containing 20 µg (800 IU) vitamin D3 to take for 6 months
Group 4: Original Finnish group, 10 µg (400 IU) vitamin D3Vitamin D3Subjects belonging to original Finnish population are given a daily supplement containing 10 µg (400 IU) vitamin D3 to take for 6 months.
Group 5: Original Finnish group, 20 µg (800 IU) vitamin D3Vitamin D3Subjects belonging to original Finnish population are given a daily supplement containing 20 µg (800 IU) vitamin D3 to take for 6 months.
Primary Outcome Measures
NameTimeMethod
Serum 25-hydroxyvitamin D (25(OH)D) concentrationsChange from baseline in serum 25(OH)D concentration at 3 and 6 months

The effect of ethnicity on the serum 25(OH)D concentration response to vitamin D supplementation will be investigated.

Secondary Outcome Measures
NameTimeMethod
Serum calcium concentrationChange from baseline in serum calcium concentration at 3 and 6 months

Markers of calcium metabolism, which are affected by vitamin D, will be measured

Serum parathyroid hormone (PTH) concentrationChange from baseline in serum PTH concentration at 3 and 6 months

Markers of calcium metabolism, which are affected by vitamin D, will be measured

Trial Locations

Locations (1)

Department of Food and Environmental Sciences, University of Helsinki

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath